News
Scientists create a mouse model to study the progression of a type of leukemia and look for more effective treatments
The model has been created by injecting tumor cells from a patient into a mouse to mimic the transformation of leukemia into a more aggressive form, making it possible to learn about the real evolution of the disease and be able to test new treatments.
IDIBELL receives 25.907€ thanks to the donations of Bonpreu and Esclat customers
In November, Bonpreu and Esclat clients made 185.804 donations that have made it possible to obtain 25.907€ for IDIBELL to develop new therapies for diabetes through the Solidarity Roundup, a tool developed by Worldcoo.
30 IDIBELL researchers among the most cited scientists in the world
The World’s Top 2% Scientists ranking is published every year by Stanford University and lists around 180.000 researchers from 22 scientific fields.
An IDIBELL project is a finalist in the VTSO Health Innovation Award
The three finalists have been selected from around thirty projects from Catalan hospitals or healthcare innovation centres. The prize is worth 15,000 euros and has the collaboration of IDIBELL-XarSMART.
The first RegenBell symposium on stem cells and regenerative medicine takes place
On November 27 and 28, the first edition of the RegenBell symposium on stem cells and regenerative medicine took place, organized by IDIBELL’s Regenerative Medicine Program (RegenBell). The event was attended by more than 165 people.
PAPILLOMATTACK: the card game to learn about the human papillomavirus enters into the L’Hospitalet classrooms
Based on gamification, the PAPILLOMATTACK science education project teaches what the human papillomavirus is, which diseases it causes and how it can be prevented with vaccination and screening programs
The ”la Caixa” Foundation promotes a promising study against pancreatic cancer
In total, 33 new basic, clinical or translational research projects of scientific excellence and social impact in the fields of study of cardiovascular diseases and infections, oncology and neurosciences will receive 25.3 million euros.
A study by IDIBELL, ICO and IGTP puts precision medicine at the service of nerve tumors
This improvement opens the door to more personalized therapeutic strategies and has been reflected in an article recently published in the journal Molecular Oncology.
Outstanding and award-winning participation of professionals from the Nursing Research Group in the international care research meeting
During the XVII International Care Research Meeting, held in Valladolid between November 15 and 17, nursing professionals from the Bellvitge University Hospital (HUB) and IDIBELL researchers presented a total of four communications. One of them, led by Jordi Adamuz, won the award for the best communication of the meeting, which was organized by the Health Care and Services Research Unit (INVESTÉN) of the Carlos III Health Institute (ISCIII).